Vascular Disease
Return to Library
|
Free Vascular Disease Articles |
|
|
|
|
AngioDynamics Appoints Shawn McCarthy Senior Vice President and General Manager of Its Peripheral Vascular Business Unit
2009 AUG 3 - (NewsRx.com) -- AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced that it has appointed Shawn P. McCarthy, 40, as Senior Vice President and General Manager of the Company's Peripheral Vascular Business Unit. Mr. McCarthy will report to Jan Keltjens, Chief Executive Officer of AngioDynamics. "Shawn brings global leadership experiences across critical functions, managing product platforms in multiple companies and countries. He has a track record of successfully commercializing new products in important therapeutic areas, in highly regulated medical device markets," said Mr. Keltjens. "Shawn possesses a deep customer understanding with significant success in marketing and sales. By joining our team he continues to build our capabilities in the marketplace and increase our capacity for future growth." Mr. McCarthy has more than 18 years of medical device commercial experience, with his last 10 years being at Johnson & Johnson. He began his career at Johnson & Johnson in 1998, as a product director for Cordis Corporation. He has held sales and marketing positions of increasing responsibility, ultimately leading to his most recent role as Vice President of Marketing at Cordis for their Endovascular and Cardiology divisions. Prior to joining Johnson & Johnson, Mr. McCarthy was the Senior Global Product Manager for the Respiratory Division of Sunrise Medical, Inc. He received his B.A. and M.B.A. from Syracuse University. "I am looking forward to building on our position as the leader in the endovenous laser market, leveraging the strength of our VenaCure EVLT™ brand, our broader vein interventional business, as well as exciting new therapies such as our Benephit® system for targeted renal drug delivery," said Mr. McCarthy. "We expect to continue advancing our relationships with physicians to deliver the best therapies available for their patients. I am committed to creating value for them, our employees, and our shareholders." Keywords: AngioDynamics, Inc., Health, Medical Devices, Oncology, Radiology, Marketing, Advertising, Cancer, Oncology, Peripheral Artery Disease, Vascular Disease This article was prepared by Clinical Oncology Week editors from staff and other reports. Copyright 2009, Clinical Oncology Week via NewsRx.com.
|
